STOCK TITAN

HCI GROUP INC 7% PFD Form 4 Filings

HCIIP OTC

Every Form 4 that HCI GROUP INC 7% PFD (HCIIP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow HCIIP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HCIIP filings page.

Rhea-AI Summary

Madhu Sanjay reported acquisition or exercise transactions in this Form 4 filing.

HCI Group, Inc. director Madhu Sanjay received a grant of 750 shares of restricted common stock effective 6/11/2026. The restricted shares were granted at $0.00 per share under HCI’s 2012 Omnibus Incentive Plan and will vest on 5/27/2027 under a restricted stock agreement.

Following the reported entries, Sanjay holds 11,988 shares directly, 41,500 shares indirectly through Universal Finance & Investments, LLC, and 2,803 shares indirectly through an IRA, with voting and investment power over the LLC-held shares.

Rhea-AI Summary

Politis Gregory reported acquisition or exercise transactions in this Form 4 filing.

HCI Group director Gregory Politis reported a compensation-related stock award rather than an open‑market trade. On June 11, 2026, he received a restricted stock grant of 750 shares of common stock at $0.00 per share under the company’s 2012 Omnibus Incentive Plan.

The 750 restricted shares will vest on May 27, 2027 under a restricted stock agreement. Additional entries dated the same day update his direct ownership of common stock, including shares held jointly with his spouse, but do not show any open‑market buying or selling.

Rhea-AI Summary

Politis Peter reported acquisition or exercise transactions in this Form 4 filing.

HCI Group, Inc. director Peter Politis received a grant of 750 shares of restricted common stock effective June 11, 2026. The award was granted by the company under its 2012 Omnibus Incentive Plan at a stated price of $0.00 per share.

The restricted shares are scheduled to vest on May 27, 2027, subject to the terms and conditions of a restricted stock agreement. This is a compensation-related equity award rather than an open-market share purchase or sale.

Rhea-AI Summary

Watts Susan reported acquisition or exercise transactions in this Form 4 filing.

HCI Group, Inc. director Susan Watts reported an equity compensation grant of common stock. She received a restricted stock award of 750 shares effective June 11, 2026, at a stated price of $0.00 per share, as part of her director compensation.

The restricted shares were granted under HCI Group’s 2012 Omnibus Incentive Plan and a restricted stock agreement, and will vest on May 27, 2027. After this grant, Watts directly holds 8,780 shares of common stock, indicating this is a relatively small, routine compensation-related award rather than an open-market transaction.

Rhea-AI Summary

Burks Robert Wayne reported acquisition or exercise transactions in this Form 4 filing.

HCI Group, Inc. director Robert Wayne Burks reported updated holdings and a new equity grant. The filing shows direct ownership of 10,632 shares of common stock, along with a restricted stock grant of 750 additional shares at a stated price of $0.0000 per share. The 750 restricted shares were granted under the company’s 2012 Omnibus Incentive Plan and are scheduled to vest on May 27, 2027 under a restricted stock agreement. A footnote indicates that some shares are held jointly with his spouse, underscoring that part of the position is shared household ownership. Overall, this is a routine compensation-related equity award rather than an open-market trade.

Rhea-AI Summary

HCI Group, Inc. Chief Financial Officer James Mark Harmsworth reported a compensation-related share withholding to cover taxes. On May 22, 2026, 13,379 shares of common stock were surrendered at $157.79 per share to satisfy estimated federal tax liability tied to the vesting of 34,000 restricted shares.

Following these entries, he reports direct ownership positions of 1,251 and 37,229 common shares in separate holdings. A prior restricted stock grant received on December 19, 2025 will vest in equal parts on October 23, 2026, October 23, 2027, and October 23, 2028 under the company’s 2012 Omnibus Incentive Plan.

Rhea-AI Summary

Saravanos Anthony reported disposition transactions in this Form 4 filing.

HCI Group, Inc. Division President Anthony Saravanos reported routine share activity related to restricted stock vesting. On May 22, 2026, 13,384 shares of common stock were surrendered at $157.79 per share to cover the estimated federal tax liability tied to the vesting of 34,000 restricted shares. The filing also lists his post-transaction holdings, including 95,233 shares held directly in one account, additional directly held shares, and indirect interests through an IRA, a custodial account for a family member, and HC Investment LLC.

Rhea-AI Summary

HCI Group, Inc. General Counsel Andrew L. Graham reported a tax-withholding share disposition related to restricted stock vesting. On May 22, 2026, he surrendered 13,379 shares of common stock at $157.79 per share to cover estimated federal tax liability tied to the vesting of 34,000 restricted shares. The filing also lists direct holdings of 1,251 shares and 43,851 shares of common stock following the transactions.

Rhea-AI Summary

HCI Group, Inc. reported that Chief Operating Officer Karin Sue Coleman surrendered 13,379 shares of common stock on May 22, 2026 to cover estimated federal tax liability tied to the vesting of 34,000 restricted shares. This was a tax-withholding disposition at $157.7900 per share, not an open-market sale. After these transactions, she continues to hold direct positions reported at 1,251.0000 and 44,946.1400 common shares.

Rhea-AI Summary

HCI Group, Inc. director and CEO Paresh Patel exercised stock options to acquire additional common shares. On February 23, 2026, he exercised options for 20,000 shares of common stock at an exercise price of $40.00 per share, described as an exercise or conversion of a derivative security.

The options were granted under HCI Group’s 2012 Omnibus Incentive Plan, with footnotes noting grant dates, exercise prices and vesting terms. The filing also describes other direct and indirect holdings, including jointly held shares with his spouse and shares held in an IRA.

4
Rhea-AI Summary

HCI Group, Inc. reported an insider equity award for its General Counsel, who is an officer of the company. On 12/19/2025, the officer received a restricted stock grant of 1,251 shares of common stock under the company’s 2012 Omnibus Incentive Plan.

The filing explains that these 1,251 restricted shares are scheduled to vest in three equal installments of 417 shares on each of October 23, 2026, October 23, 2027, and October 23, 2028, subject to continued employment. It also notes an earlier restricted stock grant of 34,000 shares effective 2/26/2021, which has met its vesting condition and is scheduled to vest on May 22, 2026 if the officer remains employed.

4
Rhea-AI Summary

HCI Group, Inc. director and Division President Anthony Saravanos reported equity awards and holdings in company common stock. On 12/19/2025, he received a restricted stock grant of 621 shares, with restrictions scheduled to lapse in three equal installments of 207 shares on October 23, 2026, October 23, 2027, and October 23, 2028, under the company’s 2012 Omnibus Incentive Plan.

The filing also notes a prior restricted stock grant of 34,000 shares effective February 26, 2021, which has met its vesting condition and is scheduled to vest on May 22, 2026, contingent on continued employment. Saravanos reports both direct and indirect ownership of HCI Group common stock, including holdings through an LLC, an IRA, and a custodial account.

Rhea-AI Summary

HCI Group, Inc. reported a new equity award to its Chief Financial Officer, James Mark Harmsworth. On 12/19/2025, he received a restricted stock grant of 1,251 shares of common stock under the company’s 2012 Omnibus Incentive Plan. These shares are scheduled to vest in three equal installments of 417 shares on October 23, 2026, October 23, 2027, and October 23, 2028, subject to continued employment.

The filing also notes an earlier restricted stock grant of 34,000 shares effective 2/26/2021, for which vesting conditions have been met and which is scheduled to vest on May 22, 2026, as long as he remains employed by the company. Following the reported transactions, Harmsworth beneficially owns 16,608 shares of common stock directly.

4
Rhea-AI Summary

HCI Group, Inc. director and Chief Operating Officer Karin Coleman reported equity awards and holdings in company common stock. The filing shows she beneficially owns 24,325.14 shares of common stock directly following the reported transactions. It also notes a previously granted award of 34,000 restricted shares, effective February 26, 2021, that are scheduled to vest on May 22, 2026 if she remains employed by the company.

In addition, she received a new restricted stock grant of 1,251 shares effective December 19, 2025. Restrictions on these shares will lapse in three equal installments of 417 shares on October 23, 2026, October 23, 2027, and October 23, 2028, subject to continued employment. Both grants were made under HCI Group’s 2012 Omnibus Incentive Plan and related restricted stock agreements.